2026-06-05
Added · Updated
An Cheng Biotechnology Co., Ltd. (OTC-listed, Stock Code 6610) completed the correction of its incomplete filing for a cash capital increase of 18,000,000 new shares with a total amount of NT$180,000,000 on June 3, 2026. Consequently, the seven-business-day review period for the effectiveness of this filing restarts from the date of correction, with effectiveness expected on June 8, 2026, assuming no major anomalies. No securities investment trust fund cases were approved, effective, or stopped on June 5, 2026.
Announcement Information
Back to Homepage
Announcement Information
Press Release
Press Release
_
Line
Printer-friendly version
Back to Previous Page
Financial Supervisory Commission Securities and Futures Bureau Daily News (June 5, 2026)
2026-06-05
I. Developments of Publicly Offered Companies
II. Securities Investment Trust Fund Cases
Related Attachments
Cases Expected to Take Effect on June 8, 2026
Cases Expected to Take Effect on June 8, 2026
Page Views: 5278
Last Updated: 2026-06-05
:::
Privacy Policy Declaration |
Information Security Policy Declaration |
Open Data Declaration of This Agency's Website |
Subscribe to Newsletter |
Latest Newsletter
Financial Supervisory Commission. All Rights Reserved. 220232 No. 18, Section 2, Xianmin Avenue, Banqiao District, New Taipei City
FSC Electronic Map
Telephone: (02) 8968-0899 Fax: (02) 8969-1215
FSC New York Representative Office: 1 E. 42 Street, 13F, New York, NY 10017, U.S.A. Contact Phone: (1-212) 317-7326
FSC London Representative Office: 46-48 Grosvenor Gardens, London SW1W 0EB, UK. Contact Phone: (44-20) 7628-1501
If you have specific suggestions for improving this Agency's Global Information Network, please email us. Thank you.
Last Updated: 2026-08-14
Visitor Count: 61516898
Back to Top
More like this from FSC
FSC published 10 documents in the last 30 days. We email you each new one the day it's published.